-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

619. Acute Myeloid Leukemias: Disease Burden and Minimal Residual Disease in Prognosis and Treatment: Poster III

Symposia: Acute Myeloid Leukemias: Disease Burden and Minimal Residual Disease in Prognosis and Treatment Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Carmen Gonzalez, MSc1*, Catia Simoes, PhD1*, Leire Burgos, PhD1*, David Martinez-Cuadron, PhD2, Sarai Sarvide1*, Diego Alignani, PhD1*, Aitziber Lopez1*, Yujuan Gui, PhD3*, Hana Komic, PhD4*, Tessa Schmachtel, MSc5*, Carmen Botella, MD, PhD6*, Raimundo Garcia Boyero, MD7*, Esther Perez Santaolla, MD8*, Cristina Gil, MD9*, Jesús Lorenzo Algarra, MD10*, Maria Jose Sayas Lloris, MD11*, Francisco Ibañez, MD12*, Laura Torres, MD13*, Isabel Cano-Ferri, MD2*, Evelyn Acuña-Cruz, MD13*, Olga Arce, MD14*, Fredrik B. Thorén, PhD4*, Michael A. Rieger, PhD5*, Jesús F. San-Miguel, MD, PhD1, Felipe Prosper, MD, PhD1, Pau Montesinos, PhD, MD2* and Bruno Paiva, PhD1*

1Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC, Pamplona, Spain
2Hospital Universitari i Politècnic La Fe, Department of Hematology, Valencia, Spain
3Single-Cell Multiomics, BD Biosciences, Vianen, Netherlands
4TIMM Laboratory at Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
5Department of Medicine 2, Hematology/Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
6Department of Hematology, Hospital General Universitario De Alicante, Alicante, Spain
7Hospital General Universitario de Castellon, Castellon, Spain
8Hospital Donostia, Donostia, Spain
9Hospital General Universitario De Alicante, Alicante, Spain
10Hospital General de Albacete, Albacete, Spain
11Hospital Dr. Peset, Valencia, Spain
12Hospital General Universitario de Valencia, Valencia, Spain
13Hospital Universitary i Politecnic La Fe, Valencia, Spain
14Hospital Universitario de Basurto, Bilbao, Spain

Lukas H. Haaksma, MD1,2*, Raffaele Palmieri3*, Jesse M. Tettero, MD, PhD1,2*, Tom Reuvekamp1,2,4*, Lok Lam Ngai, MD1,2*, Costa Bachas, PhD1,2*, Angèle Kelder1,2*, Willemijn J. Scholten1,2*, Patrycja Gradowska, PhD5,6*, Valentina Arena7*, Anderson Simione8*, Luca Maurillo, MD3*, Adriano Venditti3, Bob Lowenberg, MD, PhD6, Gert J. Ossenkoppele, MD, PhD1,2, David C. de Leeuw, MD, PhD1,2*, Maura R. V. Ikoma-Colturato, MD, PhD8*, Francesco Buccisano, MD3 and Jacqueline Cloos, PhD1,2*

1Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
3Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
4Department of Hematology, Amsterdam UMC location Universiteit van Amsterdam, Amsterdam, Netherlands
5HOVON Foundation, Rotterdam, Netherlands
6Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
7GIMEMA Foundation, Rome, Italy
8Flow Cytometry Laboratory, Hospital Amaral Carvalho, Jaú, Brazil

Morgan L Shannon, MD1*, Tian Y Zhang, MD, PhD2,3, Lori Muffly, MD4 and Gabriel N Mannis, MD2,3

1Stanford Health Care, Stanford, CA
2Division of Hematology, Department of Medicine, Stanford Health Care, Stanford, CA
3Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
4Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA

Zhong Zhang1*, Miriam Wilhelm1*, Ines Sieber1*, Hartmut Döhner, MD1 and Michaela Feuring, md2*

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Ulm University Hospital, Ulm, Germany

David Sallman, MD1, Amy F McLemore, MS2*, Onyee Chan, MD3, Andrew T. Kuykendall, MD1, Eric Padron, MD1, Zhuoer Xie, MD, MS3, Alison R. Walker, MD, MBA, MPH4, David H Spencer, MD, PhD5, Rami S. Komrokji, MD3, Jeffrey E Lancet, MD1 and Meagan Jacoby, MD6

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Wesley Chapel, FL
5Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, St Louis, MO
6Washington University-School of Medicine, Richmond Heights, MO

Katarina Micin, BS, MS1*, Tiffany Nong1*, Ellen Madarang, PharmD2*, Kiana Robles2*, Maurizio Affer, MS1*, Brittney Otero, PhD3*, Azad Gucwa3*, Felipe Novoa2*, Sion Williams4*, Ana Ayupe5*, Yi Zhou6*, Justin M. Watts, MD2 and Justin Taylor, MD1,2

1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
2Leukemia Service, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
3Mission Bio, San Francisco, CA
4Onco-Genomics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
5Onco-Genomics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami Miller of School of Medicine, Miami, FL
6Molecular Diagnostics Lab, Department of Pathology, University of Miami Miller School of Medicine, Miami, FL

Jacob Jendro1*, Lara Bischof, MD1*, Jule Ussmann, MD1*, Tung Pham Thanh1*, Donata Backhaus, MD1*, Dominic Brauer, MD1*, Vladan Vucinic, MD1*, Carmen Herling, MD1*, Marco Herling, MD1*, Georg-Nikolaus Franke, MD1*, Maximilian Merz, MD1, Klaus H Metzeler, MD1, Uwe Platzbecker, MD1, Sebastian Schwind, MD1* and Madlen Jentzsch, MD2*

1Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
2Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Sachsen, Germany

Martin Carre, MD1*, Mathieu Meunier2*, Zofia Gross, MD3*, Gaspar Aspas Requena4*, Urbain Tauveron-Jalenques5*, Emmanuelle Tavernier, MD6*, Jérome Cornillon, MD7*, Ugo Thévenet, MD8*, Boullanger Fow Heng Nadine9*, Clémence Santana10*, Clément Rocher, MD11*, Sylvain Lamure, MD, PhD12*, Amine Belhabri, MD13*, Mauricette Michallet, MD, PhD13, Adrien Contejean14*, Natacha Mauz14*, Gian Matteo Pica, MD15*, Arthur Dony15* and Mael Heiblig16*

1Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
2Department of Hematology CHU Grenoble Alpes, Grenoble, France
3Département d'Hématologie, CHU de Lyon, Pierre-Bénite, France
4CHU Clermont-Ferrand, Clermont-Ferrand, France
5Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France
6Institut De Cancérologie De La Loire, Saint Priest En Jarez, FRA
7Institut Cancerologique De La Loire, Saint-priest-en-Jarez, FRA
8Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
9CH de Roanne, Roanne, France
10Département d'Hématologie, CH de Valence, Valence, France
11Département d'Hématologie, Centre Hospitalier Bourgoin Jallieu, Bourgoin Jallieu, France
12Département d'Onco-Hématologie, Hôpitaux Nord-Ouest, Villefranche-sur-Saone, France
13Département de Cancérologie médicale, Centre Léon Bérard, Lyon, France
14Département d'Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France
15Département d'Hématologie, CH Chambery, Chambéry, France
16Service d'hématologie clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France

Sanam Loghavi, MD1*, Sa A. Wang, MD2, Wei-Ying Jen, MD, FRCPath, MA3,4*, Wei Wang, MD, PhD5*, Hong Fang5*, Shaoying Li, MD6, Sofia A. Garces, MD7*, Andres E Quesada, MD8*, Jie Xu, MD PhD2*, Chi Young Ok, MD6, Shimin Hu9*, Jeffrey L. Jorgensen, MD2, Guilin Tang, MD, PhD2*, Cedric Nasnas, MD4*, Omer Karrar10*, Ghayas C. Issa, MD4, Naval Daver, MD11, Courtney D. DiNardo, MD, MSc12, Tapan M. Kadia, MD4, Hagop M. Kantarjian, MD4, L. Jeffrey Medeiros, MD2, Farhad Ravandi, MBBS13 and Nicholas J. Short, MD4

1Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Haematology-Oncology, National University Cancer Institute, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX
6Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Hematopathology, MD Anderson Cancer Center, HOUSTON, TX
8Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
9Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
10The University of Texas MD Anderson Cancer Center, Houston, TX
11MD Anderson Cancer Center, Houston, TX
12Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
13Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Enise Ceran, MD1*, Anne Kathrin Merbach, PhD1,2*, Christian Rohde, PhD1,2*, Robert Durruthy-Durruthy, PhD3*, Adam Sciambi, PhD3*, Michelle Lotze1*, Gema Fuerte, PhD3*, Matteo Cattaneo, PhD3*, Ivan Lukic, PhD3*, Maxi Wass, MD4*, Judith Schaffrath, MD4*, Christoph Röllig, MD, MSc5*, Richard F. Schlenk, MD1*, Marina Scheller, PhD1*, Simone Kowoll6*, Jörg Steighardt, PhD6*, Bayram Edemir, MD4*, Beatrice Ludwig-Kraus, MD7*, Lutz P. Mueller, MD4*, Sabine Edemir4*, Abi Vainstein-Haras, MD8*, Ella Sorani, PhD8*, Irit Gliko Kabir, PhD8*, Shaul Kadosh, PhD8*, Cora Gromann6*, Andreas Wienke, PhD9*, Claudia Wickenhauser, MD10*, Claudia D Baldus, MD11*, Uwe Platzbecker, MD12, Hubert Serve, MD13, Martin Bornhäuser, MD14* and Carsten Müller-Tidow, MD1,2*

1Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
2European Molecular Biology Lab (EMBL), Molecular Medicine Partnership Unit, Heidelberg, Germany
3Mission Bio, South San Francisco, CA
4Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
5Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
6Coordination Centre for Clinical Trials Halle, Martin-Luther University Halle-Wittenberg, Halle, Germany
7Department of Laboratory Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany
8BiolineRx, Modi'in, Israel
9Institute of Medical Epidemiology Biometrics and Informatics, Martin Luther University Halle-Wittenberg, Halle, Germany
10Department of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany
11Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
12Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
13Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany
14National Center for Tumor Diseases (NCT/UCC) Dresden, Technical University Dresden, Dresden, Germany

*signifies non-member of ASH